These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27095521)

  • 41. Activated platelet chemiluminescence and presence of CD45+ platelets in patients with acute myocardial infarction.
    Gabbasov Z; Ivanova O; Kogan-Yasny V; Ryzhkova E; Saburova O; Vorobyeva I; Vasilieva E
    Platelets; 2014; 25(6):405-8. PubMed ID: 24102264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in the resting platelet proteome and platelet releasate between healthy children and adults.
    Cini C; Yip C; Attard C; Karlaftis V; Monagle P; Linden M; Ignjatovic V
    J Proteomics; 2015 Jun; 123():78-88. PubMed ID: 25868662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet Reactivity and Intramyocardial Hemorrhage in Patients With ST-Segment Elevation Myocardial Infarction.
    Małek ŁA; Kłopotowski M; Śpiewak M; Woźniak K; Waś J; Miśko J; Rużyłło W; Witkowski A
    Clin Appl Thromb Hemost; 2014 Jul; 20(5):553-8. PubMed ID: 23344994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study.
    Zhu TQ; Zhang Q; Qiu JP; Jin HG; Lu L; Shen J; Zhao LP; Zhang RY; Hu J; Yang ZK; Shen WF
    Int J Cardiol; 2013 May; 165(3):437-43. PubMed ID: 21940058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size.
    Wong DT; Leung MC; Das R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
    Int J Cardiol; 2013 Apr; 165(1):61-6. PubMed ID: 21875755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meta-analysis of randomized controlled trials comparing intracoronary and intravenous administration of glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction.
    Wang Y; Wu B; Shu X
    Am J Cardiol; 2012 Apr; 109(8):1124-30. PubMed ID: 22245413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [MDA formation by platelets and plasmatic BTG levels in patients suffering from acute myocardial infarction (author's transl)].
    Davì G; Traina M; Novo S; Pinto A; Piraino GL; Marano G; Alfano R
    G Ital Cardiol; 1981; 11(9):1238-41. PubMed ID: 6173283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Noncardiac applications of glycoprotein IIb/IIIa inhibitors.
    Almeda FQ; Schaer GL
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):530-8. PubMed ID: 15274167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracoronary formation and retention of micro aggregates of leukocytes and platelets contribute to postischemic myocardial dysfunction.
    Götz AK; Zahler S; Stumpf P; Welsch U; Becker BF
    Basic Res Cardiol; 2005 Sep; 100(5):413-21. PubMed ID: 15944806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomic profile of platelets during reconstitution of platelet counts after apheresis.
    Thiele T; Braune J; Dhople V; Hammer E; Scharf C; Greinacher A; Völker U; Steil L
    Proteomics Clin Appl; 2016 Aug; 10(8):831-8. PubMed ID: 27040998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased platelet distribution width is associated with ST-segment elevation myocardial infarction and thrombolysis failure.
    Cetin M; Bakirci EM; Baysal E; Tasolar H; Balli M; Cakici M; Abus S; Akturk E; Ozgul S
    Angiology; 2014 Sep; 65(8):737-43. PubMed ID: 24526792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mean platelet volume is elevated in patients with myocardial infarction with normal coronary arteries, as in patients with myocardial infarction with obstructive coronary artery disease.
    Varol E; Icli A; Ozaydin M; Erdogan D; Arslan A
    Scand J Clin Lab Invest; 2009; 69(5):570-4. PubMed ID: 19347745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomics applied to the study of platelet-related diseases: aiding the discovery of novel platelet biomarkers and drug targets.
    Parguiña AF; Rosa I; García A
    J Proteomics; 2012 Dec; 76 Spec No.():275-86. PubMed ID: 22579745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trial.
    Zhu TQ; Zhang Q; Ding FH; Qiu JP; Jin HG; Jiang L; Lu L; Zhang RY; Hu J; Yang ZK; Shen Y; Shen WF
    Chin Med J (Engl); 2013 Aug; 126(16):3079-86. PubMed ID: 23981616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial.
    Thiele H; Wöhrle J; Neuhaus P; Brosteanu O; Sick P; Prondzinsky R; Birkemeyer R; Wiemer M; Kerber S; Schuehlen H; Kleinertz K; Axthelm C; Zimmermann R; Rittger H; Braun-Dullaeus RC; Lauer B; Burckhardt W; Ferrari M; Bergmann MW; Hambrecht R; Schuler G;
    Am Heart J; 2010 Apr; 159(4):547-54. PubMed ID: 20362711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
    Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H
    J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.
    Chatterjee M; Behrendt A; Schmid M; Beck S; Schneider M; Mack A; Müller I; Geisler T; Gawaz M
    Thromb Haemost; 2017 Jan; 117(2):311-324. PubMed ID: 27929199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy.
    Gibson CM; Jennings LK; Murphy SA; Lorenz DP; Giugliano RP; Harrington RA; Cholera S; Krishnan R; Califf RM; Braunwald E;
    Circulation; 2004 Aug; 110(6):679-84. PubMed ID: 15262838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ST deviation pattern in acute myocardial infarction is not related to lesion location.
    Rott D; Greganski P; Nowatzky J; Weiss AT; Chajek-Shaul T; Leibowitz D
    J Thromb Thrombolysis; 2009 Feb; 27(2):163-7. PubMed ID: 18188509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction.
    Eicher JD; Wakabayashi Y; Vitseva O; Esa N; Yang Y; Zhu J; Freedman JE; McManus DD; Johnson AD
    Platelets; 2016; 27(3):230-9. PubMed ID: 26367242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.